Brokerages Set Allogene Therapeutics, Inc. (NASDAQ:ALLO) Target Price at $9.29
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 year price […]
Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the ten analysts that are currently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average 1 year price […]
